Combination of celecoxib, zoledronic acid benefits some with hormone-sensitive prostate cancer

In terms of salvage therapies, the three arms were essentially the same with respect to the time to first subsequent therapy post progression and the time to first life-prolonging therapy. And among the patients receiving life-prolonging therapies, there was similar exposure to various agents, such as docetaxel and abiraterone.

Dr. James and Dr. Sartor disclosed that they receive honoraria and/or have consulting or advisory roles with numerous pharmaceutical companies.